RxDoctor Payments Data

Rebecca Krzyminski, DO

Obstetrics & Gynecology · Sheridan, WYNPI 1104185065

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 42.2% of the total. Reporting peaked in 2019 at $527 and has fallen 50.8% since, to $259 in 2025.

$1,266in general payments, 2019–2025

Across 53 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$534
  • AMAG Pharmaceuticals, Inc.$128
  • Intuitive Surgical$105
  • Astellas Pharma US Inc$87
  • Lupin Inc.$61
  • Avion Pharmaceuticals$36
  • plus $315 from 14 others

What the payments were for

  • Food & beverage$1,22897%
  • Education$383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,266 in reported general payments places this provider in the 70th percentile of 58 obstetrics & gynecology providers in Wyoming.

See all obstetrics & gynecology providers in Wyoming

Medicare billing

Part B allowed, 2024
$5,955
Medicare patients
30
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol12$1,151

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Sheridan

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →